SCHEMBL9885

SCHEMBL9885

[CH]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7715636 0.96
SCHEMBL9421 0.89
Hydrochloric Acid SCHEMBL7289100 0.86
SCHEMBL574734 0.86 ALDH1A1 (0.33)
SCHEMBL1699085 0.86
SCHEMBL4588 0.86
SCHEMBL1238545 0.83 ALDH1A1 (0.32)
SCHEMBL519086 0.81
SCHEMBL237047 0.78
SCHEMBL780384 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 21631 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP claimed
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 US claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 WO claimed
CN-118239953-A Compounds for the treatment of PI3K gamma mediated diseases and uses thereof 中国科学院合肥物质科学研究院 2024-06-25 CN claimed
EP-4384160-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-06-19 EP claimed
EP-4384177-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-06-19 EP claimed
CN-115109036-B Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-06-11 CN claimed
WO-2024115465-A1 PHARMACEUTICAL COMPOUNDS AS PARP7 AND/OR PARP1 INHIBITORS Duke Street Bio Limited (GB) 2024-06-06 WO claimed
WO-2024109918-A1 GSPT1 DEGRADATION AGENT AND USE THEREOF IN MEDICINE 西藏海思科制药有限公司 2024-05-30 WO claimed
WO-2024104425-A1 KRAS INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业股份有限公司 2024-05-23 WO claimed
US-4213969-A Phosphonous acid derivatives, processes for their preparation and their use in combatting microorganisms CIBA-GEIGY CORPORATION (US) 1980-07-22 US claimed
US-4200628-A ANTIBIOTICS, BACTERICIDES SHIONOGI & CO., LTD. (JP) 1980-04-29 US claimed
EP-0010066-A2 Agent and method for influencing plant growth containing phosphonous acid peptides CIBA-GEIGY AG (CH) 1980-04-16 EP claimed
EP-0010067-A2 Process for influencing plant growth CIBA-GEIGY AG (CH) 1980-04-16 EP claimed
EP-0005070-A2 N-(2-thiazolyl)amides and their use as anti-inflammatory and immunoregulatory agents PFIZER INC. (US) 1979-10-31 EP claimed
EP-0002039-A1 Phosphonous acid derivatives, processes for their preparation and their use in combating microorganisms CIBA-GEIGY AG (CH) 1979-05-30 EP claimed
EP-0001643-A2 Aminoglycoside derivatives, process for their manufacture, pharmaceutical compositions and carboxylic acids SHIONOGI & CO., LTD. (JP) 1979-05-02 EP claimed
US-4127578-A Diene intermediates for indantetrols E. R. SQUIBB & SONS, INC. (US) 1978-11-28 US claimed
US-4037035-A Hydrophilic modified acrylic polymers particularly hydrodispersible or hydrosoluble modified acrylic polymers and method of preparing the same SOCIETE NATIONALE ELF AQUITAINE (PRODUCTION) (FR) 1977-07-19 US claimed
US-4011237-A HETEROCYCLIC SUBSTITUTED CHROMENOPYRAZOLES CIBA-GEIGY CORPORATION (US) 1977-03-08 US claimed